← Leaderboards
Anish Thomas
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularDna DamageMalignant NeoplasmsClinical TrialsTumorCancer TherapyCellsGenomicsMutationGenomeMalignant Neoplasm Of LungImmunotherapyGenomic InstabilityInsightTherapeutic TargetPhase Ii TrialGenesPhase I TrialChromosome AbnormalityDiagnosisChemotherapyImmunePathway InteractionsResponse
Grant awards (10)
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$4,075,119
ZIA · FY2025 · CA · contact PI
Development Therapeutics Branch-Translational Medicine and Therapeutics Group$1,018,780
ZIC · FY2025 · CA · contact PI
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$3,252,811
ZIA · FY2024 · CA · contact PI
Development Therapeutics Branch-Translational Medicine and Therapeutics Group$813,203
ZIC · FY2024 · CA · contact PI
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$2,219,279
ZIA · FY2023 · CA · contact PI
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$1,484,033
ZIA · FY2022 · CA · contact PI
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$1,548,129
ZIA · FY2021 · CA · contact PI
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$1,402,170
ZIA · FY2020 · CA · contact PI
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$1,420,204
ZIA · FY2019 · CA · contact PI
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies$972,086
ZIA · FY2018 · CA · contact PI